Sign in
WithdrawnNo phase

NiteCAPP_HELPS_WD: Improving Sleep and Reducing Opioid Use in Chronic Pain Patients

Key facts

Who runs it
University of Missouri-Columbia
Where
Columbia, United StatesSee the site
Trial code
Status
Withdrawn
Started
31 Mar 2022
Ended
1 Jun 2024
Type of study
Interventional, 2 groups
Treatments tested
  • NiteCAPP HELPS
  • Tapered Withdrawal
Record updated
5 August 2024
Why it stopped
NIDA R01 Awarded

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 20 criteriaShow less

Who can take part

  • 18+ yrs old
  • willing to be randomized
  • can read/understand English
  • diagnosed with chronic widespread pain and insomnia
  • prescribed opioid medication for 1+ mo, 3+ times per week
  • desire to reduce or eliminate opioid use
  • written agreement from physician prescribing opioid medication
  • no prescribed or OTC sleep meds for 1+ mo, or stabilized for 6+ wks

Who cannot take part

  • psychotropic or other medications (e.g., beta-blockers) that alter pain or sleep (medications prescribed for pain or sleep are allowed)
  • <6 mos post back surgery
  • cognitive impairment (MMSE <26)
  • sleep disorder other than insomnia [i.e., sleep apnea (apnea/hypopnea index, AHI >15), Periodic Limb Movement Disorder (myoclonus arousals per hour >15)]
  • bipolar or seizure disorder (due to risk of sleep restriction treatment)
  • other severe, untreated major psychopathology except depression or anxiety (e.g., suicidal ideation/intent, psychotic disorders)
  • other spinal disorders
  • unable to provide informed consent
  • participation in other non-pharmacological treatment for pain, sleep, or mood outside current Internal metal objects or electrical devices
  • pregnancy
  • presumptive/confirmed lumbar nerve root compression
  • confirmed lumbar spinal stenosis

Where in United States

  • University of Missouri - ColumbiaColumbia, United States

About the trial

What the trial wants to find out

This project addresses the highly significant problem of developing effective strategies for facilitating withdrawal from opioid medications. The proposed work is conceptualized within the context of a well-known theoretical framework (Cognitive Activation Theory of Stress), and the research questions are theory-driven. The team proposes to evaluate an innovative web-based version of CBT-I followed by tapered withdrawal in a randomized trial in comparison to a Treatment As Usual control followed by tapered withdrawal. The dependent measures have been well-selected to effectively evaluate the outcomes. The methodological details are rigorous.

The 2 groups in the trial

  • NiteCAPP HELPSTreatment being tested

    4 weeks of online CBT-I (1 session/week for 1 hour), followed by tapered withdrawal and motivational interviewing and check-ins.

    Treatment: NiteCAPP HELPS and Tapered Withdrawal

  • Treatment as UsualOther group

    Continuation of standard treatment for sleep and pain for 4 weeks, followed by tapered withdrawal and motivational interviewing and check-ins.

    Treatment: Tapered Withdrawal

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Impact of Improving Sleep and Reducing Opioid Use in Individuals With Chronic Pain on Central Pain Processing
Record updated
5 August 2024